palmoplantar pustulosis

AnaptysBio gets double downgrade at JPM after Imsidolimab trial failure
Seeking Alpha
Tue, 03/9/21 - 10:55 am
AnaptysBio
imsidolimab
clinical trials
palmoplantar pustulosis